Search results
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo Singapore Finance· 3 weeks agoWith the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to...
Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...
GuruFocus.com via Yahoo Singapore Finance· 1 month agoThe transaction was documented in a recent SEC Filing. Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) is a biopharmaceutical company that focuses on the development, manufacturing, and marketing ...
Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
GuruFocus.com via Yahoo Singapore Finance· 2 months agoOn June 10, 2024, Floyd Petersen, Director at Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), executed...
With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
Simply Wall St. via Yahoo Singapore Finance· 2 months agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Implied Volatility Surging for Amphastar (AMPH) Stock Options
Zacks via Yahoo Singapore Finance· 3 months agoInvestors in Amphastar Pharmaceuticals, Inc. AMPH need to pay close attention to the stock based on...
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
GuruFocus.com via Yahoo Singapore Finance· 3 months agoReported Net Revenue: $171.8 million for Q1 2024, a 23% increase from $140.0 million in Q1 2023, falling below estimates of $179.58 million. GAAP Net Income: $43.2 million, significantly exceeding ...
Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
Simply Wall St. via Yahoo Singapore Finance· 3 months agoAmphastar Pharmaceuticals (NASDAQ:AMPH) First Quarter 2024 Results Key Financial Results Revenue:...
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 3 months agoAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphastar...
Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Singapore Finance· 3 months agoRevenue: Increased 23% year-over-year to $171.8 million. Net Income: Grew over 66% to $43.2 million, with earnings per share rising to $0.81 from $0.50. Adjusted Net Income: Rose to $55.3 million ...
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
Zacks via Yahoo Singapore Finance· 3 months agoAmphastar (AMPH) delivered earnings and revenue surprises of 35.06% and 0.41%, respectively, for the...